TABLE 1.
Clinical and neuroimaging information of study participants.
| Characteristics | Descriptive |
| Age, y | 59.43 ± 7.31 |
| Female | 89 (64.0) |
| Education, y | 12 (9–16) |
| Hypertension | 27 (19.4) |
| Diabetes mellitus | 5 (3.6) |
| Dyslipidemia | 18 (12.9) |
| Present smokers | 21 (15.1) |
| Present drinkers | 32 (23.0) |
| MMSE | 28 (27–30) |
| MoCA | 25 (23–28) |
| Presence of lacunes | 6 (4.3) |
| PWMH | 1.0 (0–1.0) |
| DWMH | 1 (1.0–1.0) |
| Presence of Microbleeds | 16 (11.5) |
| BG-EPVS | 1.0 (0–1.0) |
| CSO-EPVS | 2 (1.0–2.0) |
| Total brain volume, | 1386.99 ± 127.05 |
| White matter volume | 491.84 ± 55.18 |
| Gray matter volume | 596.82 ± 43.48 |
| Hippocampus volume | 3.85±0.34 |
| VT in SVC | 1.57±0.16 |
| Dbox in SVC | 1.63±0.03 |
| VT in DVC | 1.30±0.30 |
| Dbox in SVC | 1.70±0.01 |
Data are n (%), mean (SD) or median (IQR).
MMSE, mini-mental state examination; MoCA, Montreal Cognitive Assessment; PWMH, periventricular white matter hyperintensity; DWMH, deep white matter hyperintensity; BG-EPVS, basal ganglia-enlarged perivascular spaces; CSO-EPVS, centrum semiovale-enlarged perivascular spaces; SVC, superficial vascular complex; DVC, deep vascular complex; VT, microvascular tortuosity; Dbox, fractal dimension.